文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

高频重复经颅磁刺激后慢性精神分裂症患者视觉记忆任务表现的延迟改善

Delayed improvements in visual memory task performance among chronic schizophrenia patients after high-frequency repetitive transcranial magnetic stimulation.

作者信息

Du Xiang-Dong, Li Zhe, Yuan Nian, Yin Ming, Zhao Xue-Li, Lv Xiao-Li, Zou Si-Yun, Zhang Jun, Zhang Guang-Ya, Li Chuan-Wei, Pan Hui, Yang Li, Wu Si-Qi, Yue Yan, Wu Yu-Xuan, Zhang Xiang-Yang

机构信息

Suzhou Guangji Hospital, Affiliated Guangji Hospital of Soochow University, Suzhou 215008, Jiangsu Province, China.

Department of Psychiatry, Third People's Hospital of Changshu, Changshu 215501, Jiangsu Province, China.

出版信息

World J Psychiatry. 2022 Sep 19;12(9):1169-1182. doi: 10.5498/wjp.v12.i9.1169.


DOI:10.5498/wjp.v12.i9.1169
PMID:36186505
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9521529/
Abstract

BACKGROUND: Cognitive impairments are core characteristics of schizophrenia, but are largely resistant to current treatments. Several recent studies have shown that high-frequency repetitive transcranial magnetic stimulation (rTMS) of the left dor-solateral prefrontal cortex (DLPFC) can reduce negative symptoms and improve certain cognitive deficits in schizophrenia patients. However, results are inconsistent across studies. AIM: To examine if high-frequency rTMS of the DLPFC can improve visual memory deficits in patients with schizophrenia. METHODS: Forty-seven chronic schizophrenia patients with severe negative symptoms on stable treatment regimens were randomly assigned to receive active rTMS to the DLPFC ( = 25) or sham stimulation ( = 22) on weekdays for four consecutive weeks. Patients performed the pattern recognition memory (PRM) task from the Cambridge Neuropsychological Test Automated Battery at baseline, at the end of rTMS treatment (week 4), and 4 wk after rTMS treatment (week 8). Clinical symptoms were also measured at these same time points using the Scale for the Assessment of Negative Symptoms (SANS) and the Positive and Negative Syndrome Scale (PANSS). RESULTS: There were no significant differences in PRM performance metrics, SANS total score, SANS subscores, PANSS total score, and PANSS subscores between active and sham rTMS groups at the end of the 4-wk treatment period, but PRM performance metrics (percent correct and number correct) and changes in these metrics from baseline were significantly greater in the active rTMS group at week 8 compared to the sham group (all < 0.05). Active rTMS treatment also significantly reduced SANS score at week 8 compared to sham treatment. Moreover, the improvement in visual memory was correlated with the reduction in negative symptoms at week 8. In contrast, there were no between-group differences in PANSS total score and subscale scores at either week 4 or week 8 (all > 0.05). CONCLUSION: High-frequency transcranial magnetic stimulation improves visual memory and reduces negative symptoms in schizophrenia, but these effects are delayed, potentially due to the requirement for extensive neuroplastic changes within DLPFC networks.

摘要

背景:认知障碍是精神分裂症的核心特征,但目前的治疗方法对此大多无效。最近的几项研究表明,对左侧背外侧前额叶皮质(DLPFC)进行高频重复经颅磁刺激(rTMS)可以减轻精神分裂症患者的阴性症状,并改善某些认知缺陷。然而,各研究结果并不一致。 目的:探讨对DLPFC进行高频rTMS是否能改善精神分裂症患者的视觉记忆缺陷。 方法:47例在稳定治疗方案下有严重阴性症状的慢性精神分裂症患者被随机分配,在工作日接受对DLPFC的主动rTMS(n = 25)或假刺激(n = 22),连续四周。患者在基线、rTMS治疗结束时(第4周)以及rTMS治疗后4周(第8周)进行剑桥神经心理测试自动化成套测验中的模式识别记忆(PRM)任务。同时在这些相同时间点使用阴性症状评定量表(SANS)和阳性与阴性症状量表(PANSS)测量临床症状。 结果:在4周治疗期结束时,主动rTMS组和假刺激组在PRM表现指标、SANS总分、SANS子分数、PANSS总分和PANSS子分数方面没有显著差异,但在第8周时,主动rTMS组的PRM表现指标(正确百分比和正确数量)以及这些指标相对于基线的变化显著大于假刺激组(所有P < 0.05)。与假刺激治疗相比,主动rTMS治疗在第8周时也显著降低了SANS评分。此外,第8周时视觉记忆的改善与阴性症状的减轻相关。相比之下,在第4周或第8周时,两组在PANSS总分和各分量表分数方面没有组间差异(所有P > 0.05)。 结论:高频经颅磁刺激可改善精神分裂症患者的视觉记忆并减轻阴性症状,但这些效果具有延迟性,可能是由于DLPFC网络内需要广泛的神经可塑性变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e827/9521529/3e2cdc052e30/WJP-12-1169-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e827/9521529/104c9c846da5/WJP-12-1169-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e827/9521529/294de078934d/WJP-12-1169-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e827/9521529/3e2cdc052e30/WJP-12-1169-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e827/9521529/104c9c846da5/WJP-12-1169-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e827/9521529/294de078934d/WJP-12-1169-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e827/9521529/3e2cdc052e30/WJP-12-1169-g003.jpg

相似文献

[1]
Delayed improvements in visual memory task performance among chronic schizophrenia patients after high-frequency repetitive transcranial magnetic stimulation.

World J Psychiatry. 2022-9-19

[2]
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial.

Neuropsychiatr Dis Treat. 2019-5-8

[3]
Effects of High-Frequency rTMS on Negative Symptoms and Cognitive Function in Hospitalized Patients With Chronic Schizophrenia: A Double-Blind, Sham-Controlled Pilot Trial.

Front Psychiatry. 2021-9-3

[4]
High-frequency neuronavigated rTMS effect on clinical symptoms and cognitive dysfunction: a pilot double-blind, randomized controlled study in Veterans with schizophrenia.

Transl Psychiatry. 2020-2-25

[5]
The safety and efficacy of adjunctive 20-Hz repetitive transcranial magnetic stimulation for treatment of negative symptoms in patients with schizophrenia: A double-blinded, randomized, sham-controlled study.

Indian J Psychiatry. 2020

[6]
Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.

Schizophr Res. 2019-1-29

[7]
Efficacy and safety of Transcranial Direct Current Stimulation (tDCS) on cognitive function in chronic schizophrenia with Tardive Dyskinesia (TD): a randomized, double-blind, sham-controlled, clinical trial.

BMC Psychiatry. 2023-8-24

[8]
10 Hz repetitive transcranial magnetic stimulation (rTMS) may improve cognitive function: An exploratory study of schizophrenia patients with auditory hallucinations.

Heliyon. 2023-9-9

[9]
Effects of Repetitive Transcranial Magnetic Stimulation on Working Memory Performance and Brain Structure in People With Schizophrenia Spectrum Disorders: A Double-Blind, Randomized, Sham-Controlled Trial.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2021-4

[10]
The effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia and the follow-up study.

Neurosci Lett. 2015-1-1

引用本文的文献

[1]
Early efficacy of rTMS intervention at week 2 predicts subsequent responses at week 24 in schizophrenia in a randomized controlled trial.

Neurotherapeutics. 2024-9

[2]
Placebo effects of repetitive transcranial magnetic stimulation on negative symptoms and cognition in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis.

Front Psychiatry. 2024-5-28

[3]
Combining transcranial magnetic stimulation with training to improve social cognition impairment in schizophrenia: a pilot randomized controlled trial.

Front Psychol. 2024-2-20

[4]
Is it more effective for anhedonia and avolition? A systematic review and meta-analysis of non-invasive brain stimulation interventions for negative symptoms in schizophrenia.

CNS Neurosci Ther. 2024-3

[5]
Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment, Alzheimer's disease, Alzheimer's disease-related dementias, and other cognitive disorders: a systematic review and meta-analysis.

Int Psychogeriatr. 2024-10

[6]
Editorial: Insights into structural and functional organization of the brain: evidence from neuroimaging and non-invasive brain stimulation techniques.

Front Psychiatry. 2023-6-12

本文引用的文献

[1]
Schizophrenia.

Lancet. 2022-1-29

[2]
Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research.

Biomedicines. 2021-12-30

[3]
Cognitive deficits in familial schizophrenia.

Ind Psychiatry J. 2021-10

[4]
Does the human ventromedial prefrontal cortex support fear learning, fear extinction or both? A commentary on subregional contributions.

Mol Psychiatry. 2022-2

[5]
Prefrontal cortex and depression.

Neuropsychopharmacology. 2022-1

[6]
Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway.

Biomedicines. 2021-6-25

[7]
Editorial of Special Issue "Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry".

Biomedicines. 2021-5-6

[8]
Don't Hurt Me No More: State-dependent Transcranial Magnetic Stimulation for the treatment of specific phobia.

J Affect Disord. 2021-5-1

[9]
Intermittent theta burst stimulation for negative symptoms of schizophrenia-A double-blind, sham-controlled pilot study.

NPJ Schizophr. 2021-2-12

[10]
Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis.

Psychol Med. 2020-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索